It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Mitochondrial function and innate immunity are intimately linked; however, the mechanisms how mitochondrion-shaping proteins regulate innate host defense remains largely unknown. Herein we show that mitofusin-2 (MFN2), a mitochondrial fusion protein, promotes innate host defense through the maintenance of aerobic glycolysis and xenophagy via hypoxia-inducible factor (HIF)-1α during intracellular bacterial infection. Myeloid-specific MFN2 deficiency in mice impaired the antimicrobial and inflammatory responses against mycobacterial and listerial infection. Mechanistically, MFN2 was required for the enhancement of inflammatory signaling through optimal induction of aerobic glycolysis via HIF-1α, which is activated by mitochondrial respiratory chain complex I and reactive oxygen species, in macrophages. MFN2 did not impact mitophagy during infection; however, it promoted xenophagy activation through HIF-1α. In addition, MFN2 interacted with the late endosomal protein Rab7, to facilitate xenophagy during mycobacterial infection. Our findings reveal the mechanistic regulations by which MFN2 tailors the innate host defense through coordinated control of immunometabolism and xenophagy via HIF-1α during bacterial infection.
Silwal, Kim et al. show that mitofusin-2 (MFN2), a mitochondrial fusion protein, promotes innate host defense through coordinated orchestration of immunometabolism and xenophagy via HIF-1α in macrophages during bacterial infection. This study provides insights into how mitochondria-shaping protein is involved in host defense against intracellular bacterial infection.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details





1 Chungnam National University School of Medicine, Department of Microbiology, Daejeon, Korea (GRID:grid.254230.2) (ISNI:0000 0001 0722 6377); Chungnam National University School of Medicine, Infection Control Convergence Research Center, Daejeon, Korea (GRID:grid.254230.2) (ISNI:0000 0001 0722 6377); Chungnam National University School of Medicine, Department of Medical Science, Daejeon, Korea (GRID:grid.254230.2) (ISNI:0000 0001 0722 6377)
2 Kyung Hee University, Department of Life and Nanopharmaceutical Sciences and Department of Biology, Seoul, Korea (GRID:grid.289247.2) (ISNI:0000 0001 2171 7818)
3 University of California, Department of Medicine, San Diego, USA (GRID:grid.266100.3) (ISNI:0000 0001 2107 4242)
4 Korea Advanced Institute of Science and Technology (KAIST), Department of Biological Sciences, Daejeon, Korea (GRID:grid.37172.30) (ISNI:0000 0001 2292 0500)
5 Korea Institute of Oriental Medicine, Future Medicine Division, Daejeon, Korea (GRID:grid.418980.c) (ISNI:0000 0000 8749 5149)
6 Chungnam National University School of Medicine, Infection Control Convergence Research Center, Daejeon, Korea (GRID:grid.254230.2) (ISNI:0000 0001 0722 6377); Chungnam National University School of Medicine, Department of Medical Science, Daejeon, Korea (GRID:grid.254230.2) (ISNI:0000 0001 0722 6377); Chungnam National University School of Medicine, Department of Biochemistry, Daejeon, Korea (GRID:grid.254230.2) (ISNI:0000 0001 0722 6377)
7 The Korean Institute of Tuberculosis (KIT), Korea Mycobacterium Resource Center (KMRC) & Basic Research Section, Cheongju, Korea (GRID:grid.289247.2)
8 Korea Basic Science Institute, Center for Research Equipment, Cheongju, Korea (GRID:grid.410885.0) (ISNI:0000 0000 9149 5707)
9 Chungnam National University School of Medicine, Department of Pathology, Daejeon, Korea (GRID:grid.254230.2) (ISNI:0000 0001 0722 6377)